JOY BOATRIGHT: Open Payments
NPI 1376228007 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 58 payments from 16 companies in 2025. Trend: 2023 $380 · 2024 $1,502 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $352 |
| Ardelyx, Inc. | 7 | $142 |
| GENZYME CORPORATION | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $75 |
| Madrigal Pharmaceuticals | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Boston Scientific Corporation | 1 | $19 |
Products named: DUPIXENT, IBSRELA, RINVOQ, SKYRIZI, ENTYVIO, REZDIFFRA, CREON, TREMFYA.
Industry payments across GA — which companies pay providers there.
